Anúncio
Anúncio
RCUS
Arcus Biosciences, Inc.
23.25
USDPatrocinado
-0.58
-2.43%
02 de jan., 15:59 UTC -5
Encerrado
Pós-Mercado
23.25
0.00
-0.01%
Relatórios de Lucros RCUS
Rácio de surpresa positiva
RCUS separação 17 de 31 últimas estimativas.
55%
Próximo Relatório
Data do Próximo Relatório
23 de fev. de 2026
Estimate for Q4 25 (Revenue/ EPS)
$36.88M
/-$1.06
Mudanças implicadas de Q3 25 (Revenue/ EPS)
+41.84%
/-16.54%
Mudanças implicadas de Q4 24 (Revenue/ EPS)
+41.84%
/+2.91%
Arcus Biosciences, Inc. earnings per share and revenue
On 28 de out. de 2025, RCUS reported earnings of -1.27 USD per share (EPS) for Q3 25, beating the estimate of -1.33 USD, resulting in a 4.95% surprise. Revenue reached 26.00 milhão, compared to an expected 21.83 milhão, with a 19.11% difference. The market reacted with a +2.06% price change (close before vs. close after earnings).
Looking ahead to Q4 25, 12 analistas forecast an EPS of -1.06 USD, with revenue projected to reach 36.88 milhão USD, implying an diminuir of -16.54% EPS, and aumentar of 41.84% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
enGene Holdings Inc. Common Stock
Report Date
22 de dez. de 2025 Para Q4 25
Estimativa
-$0.57
Real
-$0.73
Surpresa
-25.95%
Outlook Therapeutics, Inc. Common Stock
Report Date
19 de dez. de 2025 Para Q4 25
Estimativa
-$0.25
Real
-$0.19
Surpresa
+26.47%
Citius Oncology, Inc. Common Stock
Report Date
23 de dez. de 2025 Para Q4 25
Estimativa
-$0.12
Real
-$0.06
Surpresa
+50.98%
FAQ
What were Arcus Biosciences, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Arcus Biosciences, Inc. reported EPS of -$1.27, beating estimates by 4.95%, and revenue of $26.00M, 19.11% above expectations.
How did the market react to Arcus Biosciences, Inc.'s Q3 2025 earnings?
The stock price moved up 2.06%, changed from $19.88 before the earnings release to $20.29 the day after.
When is Arcus Biosciences, Inc. expected to report next?
The next earning report is scheduled for 23 de fev. de 2026.
What are the forecasts for Arcus Biosciences, Inc.'s next earnings report?
Based on 12
analistas, Arcus Biosciences, Inc. is expected to report EPS of -$1.06 and revenue of $36.88M for Q4 2025.
Which companies are reporting earnings today?
Verificar FXEmpire's Earnings Calendar for today's list of reporting companies.
Anúncio